ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 386 filers reported holding ENCOMPASS HEALTH CORP in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,601,639 | -2.7% | 202,526 | -1.9% | 0.44% | +4.8% |
| Q2 2023 | $13,971,916 | +30.9% | 206,349 | +4.6% | 0.42% | +27.0% |
| Q1 2023 | $10,676,046 | -3.6% | 197,339 | +6.6% | 0.33% | -5.4% |
| Q4 2022 | $11,071,488 | +27.4% | 185,111 | -3.7% | 0.35% | +18.7% |
| Q3 2022 | $8,690,000 | -31.7% | 192,124 | -15.4% | 0.29% | -22.6% |
| Q2 2022 | $12,722,000 | -13.4% | 226,974 | +9.8% | 0.38% | +2.4% |
| Q1 2022 | $14,695,000 | +9.0% | 206,645 | +0.1% | 0.37% | +17.4% |
| Q4 2021 | $13,477,000 | -1.6% | 206,507 | +13.2% | 0.32% | -1.6% |
| Q3 2021 | $13,695,000 | +12.8% | 182,505 | +17.2% | 0.32% | +15.5% |
| Q2 2021 | $12,146,000 | -6.9% | 155,658 | -2.3% | 0.28% | -4.1% |
| Q1 2021 | $13,047,000 | +10.0% | 159,306 | +11.1% | 0.29% | +3.2% |
| Q4 2020 | $11,858,000 | +47.9% | 143,408 | +16.2% | 0.28% | +21.1% |
| Q3 2020 | $8,018,000 | +14.6% | 123,390 | +9.2% | 0.23% | +8.9% |
| Q2 2020 | $6,997,000 | – | 112,976 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |